Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

Resuscitec GmbH live beim European Resuscitation Council Congress in Antwerpen

Am 16. und 17.06.2022 findet im Flanders Meeting and Convention Center in Antwerpen der European Resuscitation Council (ERC) Congress statt. 

Die Resuscitec GmbH wird dort live vertreten sein: Treffen Sie CARL persönlich und lernen Sie das CARL System sowie die CARL Therapie näher kennen. Unser CARL Support und unser Vertriebsteam stehen Ihnen vor Ort gerne für alle Fragen zur Verfügung und freuen sich darauf, Sie am Messestand C4 begrüßen zu dürfen. 

Am Freitag, dem 17.06.2022, hält Univ.-Prof. Dr. Dr. h.c. Friedhelm Beyersdorf, Ehemaliger Ärztlicher Direktor der Herz- und Gefäßchirurgie am Universitätsklinikum Freiburg, in der Queen Elisabeth Hall von 10.00 Uhr bis 11.15 Uhr einen Vortrag zum Thema ‘Controlled Automated Reperfusion of the whoLe body‘.

Ebenfalls am Freitag zwischen 10.00 Uhr und 11.15 Uhr findet im Gorilla Room eine Poster Session statt. Jan-Steffen Pooth, Arzt am Universitätsklinikum Freiburg, wird dort zwei Poster zu den Themen „Serum proteome alterations during conventional and extracorporeal resuscitation in pigs“ und „Visualization of cerebral blood flow in extracorporeal cardiopulmonary resuscitation in a porcine model of prolonged cardiac arrest“ vorstellen.

< Zurück